Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6382111 | 7105388 | F | 6382111-7 | 20090505 | 20090925 | 20090930 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-14762819 | BRISTOL-MYERS SQUIBB COMPANY | 59 | YR | M | Y | 67 | KG | 20090930 | OT | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6382111 | 1012353023 | PS | CETUXIMAB | 2 | INTRAVENOUS | 442MG -24MAR09;ON 05MAY09 RECEVIED 49 ML(2MG/ML)EXPIRED DRUG;STOPPED;THEN RECEIEVD 5 MLUPDATE DRUG | |||||
| 6382111 | 1012353024 | SS | CARBOPLATIN | 1 | INTRAVENOUS | AUC5 | |||||
| 6382111 | 1012353025 | SS | GEMCITABINE | 1 | INTRAVENOUS | RECENT INF:21APR09 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6382111 | 1012353023 | NON-SMALL CELL LUNG CANCER |
| 6382111 | 1012353024 | NON-SMALL CELL LUNG CANCER |
| 6382111 | 1012353025 | NON-SMALL CELL LUNG CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6382111 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6382111 | EXPIRED DRUG ADMINISTERED |
| 6382111 | NO ADVERSE EVENT |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6382111 | 1012353023 | 20090324 | |||
| 6382111 | 1012353024 | 20090324 | |||
| 6382111 | 1012353025 | 20090324 |